Hussain Zain S, Khan Asher, Loya Asad, Shah Kaushal, Woreta Fasika A, Riaz Kamran M
University of Medicine and Health Sciences, Basseterre, Saint Kitts and Nevis.
Department of Ophthalmology, Dean McGee Eye Institute, Oklahoma City, OK, USA.
Clin Ophthalmol. 2023 Mar 14;17:849-860. doi: 10.2147/OPTH.S401167. eCollection 2023.
To investigate the association between early lifetime substance use on the development of severe visual acuity impairment or blindness on a national level.
National Survey of Drug Use and Health data was used to identify cases of substance use before 21* years of age, within the past year, and cases of self-reported blindness or visual impairment. Univariable and multivariable binary logistic regression with time-dependency was performed to evaluate odds of visual impairment influenced by 16 substances separated into three classes: prescription, non-prescription, and illicit drugs. Adjusted variables of interest included gender, marital status, race, level of education, total family income, poverty level, population density, and history of chronic disease.
55,824 total responses were analyzed with 2577 (4.6%) cases of self-reported blindness or significant visual impairment. All early-use substance categories, including prescription, non-prescription, and illegal substances, were significantly associated with self-reported VI (OR 2.068, CI 1.451-2.949, <0.001; OR 1.352, CI 1.227-1.489, <0.001); OR 1.211, CI 1.086-1.352, <0.001), respectively). Non-prescription substances displayed parallel significances amongst all constituents (alcohol, cigarettes, inhalants, and marijuana) (OR=1.227, CI 1.12-1.344, <0.001; OR 1.363, CI 1.243-1.495, <0.001; OR 1.418, CI 1.134-1.774; OR 1.388, CI 1.27-1.518, <0.001, respectively). Univariable and multivariable analysis revealed several significant demographical and clinical adjustors.
Early lifetime use of all three classes of substances is associated with enhanced odds of subsequent visual impairment or blindness. Several readily available and commonly used substances have a greater risk. These findings may help clinicians and public health agencies in mitigation ventures including education, prevention, and rehabilitation efforts.
在全国范围内调查早年使用药物与严重视力损害或失明发展之间的关联。
利用全国药物使用和健康调查数据,确定21岁之前、过去一年内使用药物的案例,以及自我报告的失明或视力损害案例。采用具有时间依赖性的单变量和多变量二元逻辑回归,评估16种分为三类的药物(处方药、非处方药和非法药物)对视力损害几率的影响。感兴趣的调整变量包括性别、婚姻状况、种族、教育程度、家庭总收入、贫困水平、人口密度和慢性病病史。
共分析了55824份回复,其中2577例(4.6%)为自我报告的失明或严重视力损害。所有早期使用的药物类别,包括处方药、非处方药和非法药物,均与自我报告的视力损害显著相关(比值比分别为2.068,置信区间1.451 - 2.949,<0.001;1.352,置信区间1.227 - 1.489,<0.001;1.211,置信区间1.086 - 1.352,<0.(此处原文疑似有误,应补充完整))。非处方药在所有成分(酒精、香烟、吸入剂和大麻)中显示出相似的显著性(比值比分别为1.227%,置信区间1.12 - 1.344,<0.001;1.363,置信区间1.243 - 1.495,<0.001;1.418,置信区间1.134 - 1.774;1.388,置信区间1.27 - 1.518,<0.001)。单变量和多变量分析揭示了几个显著的人口统计学和临床调整因素。
早年使用这三类药物均与随后视力损害或失明的几率增加有关。几种容易获得和常用的药物风险更大。这些发现可能有助于临床医生和公共卫生机构开展包括教育、预防和康复努力在内的缓解风险工作。